SuperCrowd

CEO at The Burlington HC Research Group, Inc. - addressing the problem of drug resistance in cancer and other diseases

This year, in the US alone, approximately 600,000 cancer patients will pass away, and for 80% to 90% of those patients, their death will be due to a tumor no longer responds to current treatments at dose levels that the patient can tolerate or survive. The death of a loved one can change the lives of those around them in ways that can be permanent and often difficult to endure. I have experienced this myself because when I was only about 1 year old my father died due to a drug-resistant cancer. Please join me if you would like to learn more. Thanks in advance for your time.

Catch at SuperCrowd26 featuring PurposeBuilt100™

August 25–27, 2026 · Live on SuperCrowd.tv, syndicated via the e360tv Network · Founders Circle tickets $100 (includes the hardbound Book)

Get tickets

Get Superpowers for Good in your inbox

Impact crowdfunding stories, live shows and deals from the SuperCrowd — free.